Cross-border EU supplement sales and mutual recognition

The EU single market promises free movement of goods, but supplements sit in an area where national rules still differ a lot — maximum levels, permitted botanicals, the status of certain ingredients. So a supplement lawfully sold in one member state isn't automatically free to sell in another. The principle of mutual recognition is meant to bridge this, but it's not a magic pass. Understanding how cross-border supplement sales actually work matters for any brand expanding across the EU.

The harmonization gap

Because the EU never set harmonized maximum levels, and botanicals and some ingredients are governed nationally, a supplement legal in one country can breach another's rules — a vitamin above the destination's cap, a botanical on its restricted list. So crossing a border can mean meeting a different rulebook, not just translating a label. The gaps in harmonization are exactly where cross-border friction lives.

What mutual recognition does

The mutual recognition principle holds that a product lawfully marketed in one member state should, in general, be allowed in another, even if it doesn't meet the destination's national rules — unless the destination can justify a restriction on grounds like public health. The Mutual Recognition Regulation provides a process around this. It's a real tool for moving products across borders without full reformulation — but it has limits.

Its limits

Mutual recognition isn't automatic acceptance. A destination member state can refuse or restrict a product where it can justify doing so, particularly on safety grounds — and supplement maximum levels are often framed around safety. So a high-dose product lawful in a permissive country may still be challenged in a stricter one. Relying on mutual recognition for a product far outside a destination's norms is risky; it works best at the margins, not for large gaps.

The practical approach

For a brand expanding across the EU, the realistic approach combines both paths: design products to meet the rules of the target markets where you can (so mutual recognition isn't even needed), and use mutual recognition deliberately where a product is lawful at origin and the gap to the destination is defensible. Either way, it depends on knowing each market's rules against your formula — the maximum levels, the botanical positions, the ingredient statuses — so you know where a product travels freely and where it needs care.

This is general information, not regulatory or legal advice. National requirements and the application of mutual recognition differ across the EU and change over time, so confirm current rules with the relevant authority or a qualified regulatory expert before relying on them.

Where Lemoniq fits

Lemoniq checks each formula against the rules of the markets you select — maximum levels, botanical positions, ingredient statuses — so you can see where a product already complies (and travels freely), and where it relies on mutual recognition or needs a market-specific variant. Cross-border expansion becomes a known map, not a gamble.

The takeaway

A supplement lawful in one EU market isn't automatically sellable in another, because national rules differ — and mutual recognition helps but has real limits, especially on safety grounds. Knowing each market's rules against your formula, and designing or using mutual recognition deliberately, is what makes EU cross-border expansion work.

Lemoniq maps your formula against each EU market's rules, so you know where it travels. See how it works